Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- PE ratio
- —
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 900
- Avg volume
- 14,938
- Day's range
- $0.18 – $0.19
- Shares out
- —
- Stochastic %K
- 7%
- Beta
- —
- Analysts
- Strong Buy
- Price target
- —
Company profile
Sona Nanotech Inc. operates as a nanotechnology life sciences company in the United States and Canada The company researchers and develops gold nanoparticles for potential therapies, including photothermal therapy, tumor targeting activity, anti-bacterial activity, and drug delivery vehicle, as well as diagnostics, such as diagnostic markers for imaging and immunoassay and biosensing. It also engages in the developme...
Show more
Sona Nanotech Inc. operates as a nanotechnology life sciences company in the United States and Canada The company researchers and develops gold nanoparticles for potential therapies, including photothermal therapy, tumor targeting activity, anti-bacterial activity, and drug delivery vehicle, as well as diagnostics, such as diagnostic markers for imaging and immunoassay and biosensing. It also engages in the development of targeted hyperthermia therapy, a photo thermal therapy for the treatment of cancer tumors; and diagnostic tools comprising lateral flow assay rapid and bovine tuberculosis tests. The company was founded in 2013 and is based in Halifax, Canada.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 902 442 0653
- Website
- https://www.sonanano.com
- Address
- Purdy’s Wharf Tower II, Suite 2001 1969 Upper Water Street, Halifax, Canada
Latest news
No headlines yet.
